(CNN) – As September 20 approaches, there have been internal conversations within the Biden administration about reducing the ambitious covid-19 vaccine booster dose plan unveiled by top federal health officials last month.
This is due to concerns that the US Food and Drug Administration is only prepared to recommend booster doses for those who received the Pfizer / BioNTech vaccine, said an official familiar with the discussions. At this time, the agency does not have enough data on Moderna to make that recommendation, according to the official.
A person familiar with the matter said there was a meeting between top federal health officials and White House staff Thursday to discuss the booster dose issue. At the meeting, officials warned that more time may be needed before there is enough data to recommend boosters for all adults, the person said.
FDA officials previously tried to get the White House not to put a specific date when people should wait for booster doses, but they did it anyway.
White House coronavirus response coordinator Jeff Zients and federal health officials have repeatedly said that the Sept. 20 launch of the booster vaccination was pending approval from the FDA and the Centers for Disease Control. and US Disease Prevention.
The FDA is already evaluating the data submitted by Pfizer / BioNTech for approval of a booster dose. Moderna said Wednesday that it began submitting data to the FDA to support giving people a booster dose of its vaccine six months after their second dose.